|Mr. Gregory William Fry||MD & CEO||343.1k||N/A||1966|
|Mr. Benedict James Rohr||Chief Operating Officer||240.36k||N/A||N/A|
|Mr. Steven Luke Jackson BEc, C.P.A., CPA||CFO & Company Sec.||N/A||N/A||N/A|
|Ms. Elizabeth Caiulo||Admin. Professional||N/A||N/A||N/A|
|Ms. Beck Howe||Sales & Marketing Professional||N/A||N/A||N/A|
|Ms. Stephanie Yip||Marketing Director||N/A||N/A||N/A|
|Ms. Robyn Ingersole||Chief Exec. Officer of Naturally Australian Products||N/A||N/A||N/A|
Eve Health Group Limited, together with its subsidiaries, engages in the production and marketing of nutrition, health, and wellness products in Australia, North America, China, and Asia. The company operates through three segments: Jenbrook, Meluka, and Investment. It provides organic tea tree oils and essential oils; and distributes botanical oils. The company also offers organic raw honey and raw honey probiotic concentrates; and contract manufacturing services. The company was formerly known as EVE Investments Limited. Eve Health Group Limited was incorporated in 2003 and is based in Subiaco, Australia.
EVE Health Group Limited’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.